Get the Stockscreener App
15.85
1.21%
0.19
Angiodynamic Inc stock is traded at $15.85, with a volume of 330.04K.
It is up +1.21% in the last 24 hours and up +21.92% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$15.66
Open:
$15.71
24h Volume:
330.04K
Relative Volume:
0.74
Market Cap:
$655.12M
Revenue:
$320.17M
Net Income/Loss:
$-36.74M
P/E Ratio:
-17.90
EPS:
-0.8856
Net Cash Flow:
$-2.86M
1W Performance:
+1.02%
1M Performance:
+21.92%
6M Performance:
+44.48%
1Y Performance:
+81.56%
1-Day Range:
$15.54
$15.94
1-Week Range:
$15.22
$16.11
52-Week Range:
$8.65
$16.11
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
15.85 | 650.99M | 320.17M | -36.74M | -2.86M | -0.8856 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
AngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings - directorstalkinterviews.com
AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC - MarketBeat
Segall Bryant & Hamill LLC Trims Stock Position in AngioDynamics, Inc. $ANGO - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
AngioDynamics (ANGO) SVP Warren Nighan Jr. sells 23,370 shares at $14.72 - Stock Titan
AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards - Stock Titan
AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Live webcast set for AngioDynamics' Aug. 11 presentation - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax - Stock Titan
AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units - Stock Titan
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant - Stock Titan
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld - Stock Titan
AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding - Stock Titan
Form 4 AngioDynamics Inc For: 22 July By Investing.com - Investing.com Canada
AngioDynamics (ANGO) director receives 11,887-share stock award - Stock Titan
AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights - Stock Titan
ETFs Investing in AngioDynamics, Inc. Stocks - TradingView
AngioDynamics Inc (ANGO) director awarded 11,887 shares in annual grant - Stock Titan
AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations - Stock Titan
AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations - Stock Titan
AngioDynamics (ANGO) SVP covers tax obligations through share withholding - Stock Titan
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In - Seeking Alpha
AngioDynamics, Inc. $ANGO Shares Bought by Bastion Asset Management Inc. - MarketBeat
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade) - Seeking Alpha
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - TradingView
AngioDynamics, Inc. Q4 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics (NASDAQ: ANGO) details device portfolio and risk factors - Stock Titan
ANGIODYNAMICS INC FY 2026: Revenue $320.17M, EPS ($0.88) — 10-K Summary - TradingView
Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? E - GuruFocus
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
AngioDynamics, Inc. 2026 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-07-14 - Seeking Alpha
AngioDynamics Releases Q4 2026 Financial Results - AlphaStreet
Record 2026 sales as AngioDynamics (NASDAQ: ANGO) grows Med Tech 18% - Stock Titan
AngioDynamics: Fiscal Q4 Earnings Snapshot - KVUE
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Enterprise value to revenue forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to earnings forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Enterprise value to EBIT forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
AngioDynamics Inc. (ANGO) Rises 5.25%: Support and Resistance Levels in FocusInitial Balance - dars.gov.et
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):